Amgen (NASDAQ:AMGN – Free Report) had its target price cut by TD Cowen from $370.00 to $360.00 in a research report released on Wednesday morning, Benzinga reports. They currently have a buy rating on the medical research company’s stock. A number of other brokerages also recently weighed in on AMGN. Daiwa Capital Markets upgraded Amgen […]

Related Keywords

Canada , Maryland , United States , Leerink Partnrs , Amgen Inc , Veracity Capital , Cohen Investment Advisors , Royal Bank , Marshall Financial Group , Amgen , Everett Harris Co , Free Report , Capital Markets , Moderate Buy , Get Free Report , State Retirement , Pension System , Investment Advisors , Financial Group , Amgen Daily , Nasdaq Amgn , Amgn , Medical , 03116210 , Lower Price Target , Td Cowen ,